AGREEMENT AND PLAN OF MERGER BY AND AMONG NEW YORK GLOBAL INNOVATIONS INC., ARTEMIS ACQUISITION CORP. AND ARTEMIS THERAPEUTICS INC. AUGUST 2, 2016Merger Agreement • August 3rd, 2016 • New York Global Innovations Inc. • Miscellaneous chemical products • Delaware
THIS AGREEMENT AND PLAN OF MERGER is entered into as of August 2, 2016 by and among New York Global Innovations Inc., a Delaware corporation (“Parent”), Artemis Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (“Acquisition Corp.”), and Artemis Therapeutics Inc., a Delaware corporation (the “Company”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 3rd, 2016 • New York Global Innovations Inc. • Miscellaneous chemical products • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 2, 2016, between New York Global Innovations Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECOND AMENDMENT TO SERIES A WARRANTSeries a Warrant • August 3rd, 2016 • New York Global Innovations Inc. • Miscellaneous chemical products
SECOND AMENDMENT dated August 2, 2016 to Series A Warrant ("Series A Warrant") dated April 8, 2008, as amended on January 19, 2010 (the “First Amendment”), issued by New York Global Innovations Inc. (formerly known as Inksure Technologies, Inc.) ("Issuer") to Smithfield Fiduciary LLC ("Holder") for 2,153,433 shares of Common Stock of Issuer.
